Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators.

Santos, Tírcia C; Morton, Tatjana J; Moritz, Martina; Pfeifer, Sabine; Reise, Kathrin; Marques, Alexandra P; Castro, António G; Reis, Rui L; van Griensven, Martijn

Santos, Tírcia C; Morton, Tatjana J; Moritz, Martina; Pfeifer, Sabine; Reise, Kathrin; Marques, Alexandra P; Castro, António G; Reis, Rui L; van Griensven, Martijn.

Affiliation

Santos TC; 3B's Research Group-Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Taipas, Guimarães, Portugal.

Tissue Eng Part A ; 19(7-8): 834-48, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23173745

Subject(s)

Bone and Bones/drug effects; Fibroblast Growth Factor 2/pharmacology; Neovascularization, Physiologic/drug effects; Starch/pharmacology; Tissue Engineering; Tissue Scaffolds/chemistry; Vascular Endothelial Growth Factor A/pharmacology; Adult; Animals; Cell Tracking; Female; Humans; Luminescent Measurements; Mice; Mice, Nude; Mice, Transgenic; Microvessels/drug effects; Middle Aged; Polyesters/pharmacology; Vascular Endothelial Growth Factor Receptor-2/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Starch / Bone and Bones / Fibroblast Growth Factor 2 / Neovascularization, Physiologic / Tissue Engineering / Vascular Endothelial Growth Factor A / Tissue Scaffolds Limits: Adult / Animals / Female / Humans / Middle aged Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google